Fig. 3
From: Efficiently targeted therapy of glioblastoma xenograft via multifunctional biomimetic nanodrugs
The toxicity of nanodrugs to cells detected by MTT method. A Toxicity of CMS/PEG nanoparticles at different concentrations to U87 MG cells and HA cells. B Toxicity of CMS/PEG at the concentration of 25 μg/ml to U87 MG cells at the indicated time points. C Toxicity of CMS/PEG-DOX at the indicated concentrations to U87 MG cells with or without infrared laser irradiation (808 nm laser, 1 W·cm− 2). D Toxicity of CMS/PEG-DOX-M at the indicated concentrations to U87 MG cells with or without infrared laser irradiation (808 nm laser,1 W·cm− 2). E Toxicity of CMS/PEG-DOX or CMS/PEG-DOX-M at the indicated concentrations to U87 MG cells (F) Toxicity of CMS/PEG-DOX or CMS/PEG-DOX-M at the indicated concentrations to U87 MG cells with or without infrared laser irradiation (808 nm laser,1 W·cm− 2). G The toxicity of 808 nm laser (1 W·cm − 2) irradiation for different times to U87 MG or HA cells. H Toxicity of free DOX at the indicated concentrations to U87 MG or HA cells. MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; CMS, Cu2MoS4; PEG, polyethylene glycol; DOX, doxorubicin; M, cell membrane of U87 MG cells